|
Market Closed -
Toronto S.E.
02:50:59 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.4700 CAD | 0.00% |
|
-4.08% | +3.30% |
| Aug. 27 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| Aug. 20 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 47x | - | 1.75x | 21.77x | 51.08x | 59.14M | |
| -.--% | -.--% | 16.91x | 1.53x | 0.69x | 10.24x | 11.14x | 15.07B | |
| 2.22% | 2.54% | 16.81x | 1.73x | 0.76x | 7.89x | 9.89x | 6.55B | |
| 1.07% | 1.33% | 20.89x | 2.32x | 0.8x | 13.4x | 13.66x | 6.47B | |
| 2.88% | 3.29% | 14.69x | 2.18x | 0.9x | 6.23x | 8.47x | 4.14B | |
| 5.64% | 6.19% | 14.27x | 4.32x | 1.23x | 7.5x | 14.07x | 3.17B | |
| 5.01% | 5.55% | 14.41x | 2.73x | 0.61x | 4.72x | 7.77x | 3.19B | |
| 4.67% | 5.1% | 13.8x | 6.24x | 0.83x | 6.23x | 8.66x | 2.94B | |
| 2.09% | 2.54% | 19.42x | 3.4x | 0.57x | 7.29x | 11.93x | 1.46B | |
| 0.02% | -.--% | -124.28x | 2.55x | 0.43x | 15.25x | 65.89x | 1.42B | |
| 3.32% | 4.52% | 13.92x | 0.87x | 0.29x | 2.68x | 6.74x | 963M | |
| 6.11% | 5.34% | 20.22x | 2.38x | 0.82x | 7.57x | 18.02x | 867M | |
| 1.29% | 1.88% | 27.66x | 7.54x | 1x | 13.64x | 21.15x | 841M | |
| Average | 2.86% | 3.19% | 8.90x | 3.15x | 0.82x | 9.57x | 19.11x | 3.63B | |
| Weighted average by Cap. | 1.99% | 2.24% | 12.75x | 2.48x | 0.76x | 9.12x | 12.84x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
